Evidence map›Paper›PMID 30066804›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2018

Decline in hepatitis B and C prevalence among hemodialysis patients in Tocantins, Northern Brazil.

Valéria Maciel Cordeiro, Bruno César Teodoro Martins, Sheila Araujo Teles, Regina Maria Bringel Martins, Karla Prado de Souza Cruvinel, Márcia Alves Dias de Matos, Jonio Arruda Luz, Regiane Aparecida Dos Santos Soares Barreto, Juliana Araujo Teles, Nathália Carneiro Santos and 2 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Seroprevalence and Spatial Distribution of Hepatitis C Virus in Bahia, Brazil.The American journal of tropical medicine and hygiene · 2021
    Article
  6. Serological and molecular characterization of hepatitis B virus infection in chronic kidney disease patients from Rio de Janeiro, Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Valéria Maciel CordeiroCentro Universitário UnirG, Gurupi, Tocantins, Brazil.
Bruno César Teodoro MartinsUniversidade Federal de Goiás, Faculdade de Enfermagem, Goiânia, Goiás, Brazil.
Sheila Araujo TelesUniversidade Federal de Goiás, Faculdade de Enfermagem, Goiânia, Goiás, Brazil.
Regina Maria Bringel MartinsUniversidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Goiânia, Goiás, Brazil.
Karla Prado de Souza CruvinelPontifícia Universidade Católica de Goiás, Departamento de Enfermagem, Goiânia, Goiás, Brazil.
Márcia Alves Dias de MatosUniversidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Goiânia, Goiás, Brazil.
Jonio Arruda LuzHospital de Doenças Tropicais de Araguaína, Serviço de Fígado e Hepatites, Araguaína, Tocantins, Brazil.
Regiane Aparecida Dos Santos Soares BarretoUniversidade Federal de Goiás, Faculdade de Enfermagem, Goiânia, Goiás, Brazil.
Juliana Araujo TelesHospital Naval Marcilio Dias, Clínica Médica, Rio de Janeiro, Rio de Janeiro, Brazil.
Nathália Carneiro SantosPontifícia Universidade Católica de Goiás, Faculdade de Medicina, Goiânia, Goiás, Brazil.
Karlla Antonieta Amorim CaetanoUniversidade Federal de Goiás, Faculdade de Enfermagem, Goiânia, Goiás, Brazil.
Megmar Aparecida Dos Santos CarneiroUniversidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Goiânia, Goiás, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection control measures have been responsible for a decline in the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in hemodialysis patients. In Brazil, these measures have been in place since 1996. The aim of this study was to evaluate the current HBV and HCV epidemiology among hemodialysis patients in the State of Tocantins comparing them with those found 14 years ago. There was a significant decline in hepatitis B surface antigen (HBsAg) and anti-HCV prevalence from 4% and 13% in 2001 to 0.8% and 2.8% in 2014-2015, respectively (p < 0.05). Variables related to hemodialysis environment such as working shift and length of time on hemodialysis treatment were no longer associated to HCV and HBV exposure in 2014-2015. A high prevalence of self-reported hepatitis B vaccination was observed in both periods, but only 30% of the individuals showed serological profile of effective previous immunization, suggesting a low compliance with surveillance of hepatitis B immunization in hemodialysis centers. The significant decline in viral hepatitis B and C prevalence in hemodialysis patients in Tocantins underscores the importance of infection control measures, but the low frequency of protective serological profile after immunization against hepatitis B points to the need for greater vigilance of the patients' vaccination.

Indexed as

AdolescentAdultAgedAged, 80 and overBrazilFemaleHepacivirusHepatitis BHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B virusHepatitis CHepatitis C AntibodiesHumansMaleMiddle AgedHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis C Antibodies

Identifiers

PMID30066804
PMCPMC6069268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.